Laura Brege - 16 Aug 2024 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
16 Aug 2024
Net transactions value
+$12,810
Form type
4
Filing time
19 Aug 2024, 08:25:46 UTC
Previous filing
13 Jun 2024
Next filing
02 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Purchase $12,810 +1,000 +6% $12.81 17,552 16 Aug 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.